Partnering Solutions
-
Avance Clinical's Specialist Areas Of Focus
8/8/2024
Avance Clinical offers deep scientific expertise and extensive knowledge across a range of specialized therapeutic indications, consistently achieving global regulatory approvals.
-
eClinicalGPS – Flexible Delivery Model
6/13/2018
Clinical trial financial technology available in three unique delivery models.
-
Your Trusted Packaging And Serialization Partner
2/6/2018
How your manufacturing, packaging, serialization, and clinical distribution can benefit with a contract partner.
-
Accelerate Your Clinical Development Program With Novotech
9/29/2022
Novotech delivers unmatched experience as the Asia-Pacific’s leading CRO with 11 dedicated offices, expert teams and deep local regulatory knowledge.
-
Accelerating Biologics Through Development Milestones
9/4/2024
Whether you're aiming to run a pivotal trial or multiple studies, discover how Veristat's full-service support can drive your biologic therapies from inception to market success.
-
Human Abuse Potential
4/17/2024
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
-
Contract Stick Packaging Services For Pharmaceutical And Nutraceutical Applications
5/19/2015
Ropack recognizes that the unique design of stick-pack offers multiple benefits – for pharma and natural health products as well as to consumers.
-
Pharmaceutical Clinical Trial Distribution Services
1/26/2023
Contracting an in-country pharmaceutical clinical depot brings efficiencies to your clinical trial distribution. From its facilities in Montreal, Quebec, Ropack handles most paperwork, permissions, components, warehousing, packaging, distribution, collection, and destruction as a single project.
-
High Speed Blistering, Cartoning, And Serialization Capabilities
11/14/2016
The BEC 300, manufactured by Uhlmann, is the eighth blister line at Ropack Pharma Solutions. The single-lane unit integrates blistering, cartoning, and serialization.
-
Pandemic Response Assessment
8/9/2021
In the face of the COVID-19 pandemic, biopharmaceutical companies had to react quickly to develop and implement what were frequently large scale crisis response initiatives. Read how now is the time to assess the changes that were implemented and refine business continuity plans to ensure regulatory compliance, patient safety, and organizational preparedness now and into the future.